NICE releases protocol on ovarian cancer diagnostic tests

The National Institute for Health and Care Excellence (NICE) has published a final assessment and final scope on the assessment of tests in secondary care to identify people at high risk of ovarian cancer. These documents can be found on their website.

While serum tumour markers can facilitate early diagnosis, the NICE diagnostics assessment programme will evaluate the cost-effectiveness of using serum tumour marker tests to assist diagnosis of suspected ovarian cancer in secondary care.

You can read the final scope here. This guidance is still in development and is expected to be published in November 2017.

As one of the registered professional group stakeholders, the IBMS will review this guidance in due course.